MTR and breast carcinoma: A number of studies have examined MTHFR and MTR polymorphisms and found that variant genotypes of MTHFRrs1801133 GA + AA10, MTHFRrs1801131GG11 and MTRrs1805087 GA2 were associated with a decreased risk of breast cancer.